Strong Industry Presence StudyKIK is recognized as a global leader in patient recruitment and retention strategy, with a proven track record of connecting over 3.1 million patients to clinical trials. This extensive experience provides a solid foundation for expanding into new therapeutic areas and markets.

Innovative Technology Platform With an award-winning oncology study app and a comprehensive platform that includes telemedicine, eConsent, and mobile retention solutions, StudyKIK offers cutting-edge technology that can be leveraged to enhance reach and engagement for diverse clinical research initiatives.

Strategic Acquisition Backing Having been acquired by Syneos Health, a major player in the industry, StudyKIK benefits from enhanced resources, industry reach, and credibility, making it an attractive partner for CROs, biotech, and pharmaceutical companies seeking reliable patient recruitment solutions.

Expansion & Innovation Recent launches of pre-screening services and in-house patient contact departments demonstrate StudyKIK’s commitment to process innovation and efficiency, offering potential opportunities to serve clients seeking integrated, streamlined recruitment workflows.

Growth & Market Potential With revenues estimated between $10 million and $50 million and a growing client base, StudyKIK shows strong market traction and the potential to scale further, especially by targeting sponsors and CROs looking for proven, tech-enabled recruitment solutions.